BRIEF published on 05/08/2026 at 22:35, 5 months 25 days ago Integrated BioPharma Reports Decrease in Quarterly Revenue Financial Results Revenue Decline Net Loss Operating Loss Contract Manufacturing
PRESS RELEASE published on 05/08/2026 at 22:30, 5 months 25 days ago Integrated BioPharma Reports Results for its Quarter Ended March 31, 2026 Integrated BioPharma, Inc. reports $10.1M revenue for Q1 2026, a 27.3% decrease from Q1 2025. Operating loss of $1.1M in Q1 2026. Financial summary provided Financial Results Revenue Quarterly Report Operating Loss Integrated BioPharma
BRIEF published on 02/11/2026 at 22:35, 8 months 19 days ago Integrated BioPharma Announces Q4 2025 Financial Results Financial Results Revenue Decline Net Loss Operating Loss Customer Dependency
PRESS RELEASE published on 02/11/2026 at 22:30, 8 months 19 days ago Integrated BioPharma Reports Results for Its Quarter Ended December 31, 2025 Integrated BioPharma, Inc. reports financial results for Q4 2025, showing a $1.3M decrease in revenue and operating loss compared to Q4 2024. Key financial details provided Financial Results Revenue Decrease Operating Loss Integrated BioPharma Quarterly Performance
BRIEF published on 11/10/2025 at 21:55, 11 months 22 days ago Integrated BioPharma Reports Financial Results for Q3 2025 Financial Results Net Income Revenue Decline Operating Income Contract Manufacturing
PRESS RELEASE published on 11/10/2025 at 21:50, 11 months 22 days ago Integrated BioPharma Reports Results for Its Quarter Ended September 30, 2025 Integrated BioPharma, Inc. reports financial results for the quarter ended September 30, 2025, with $12.7 million revenue and insights on operating income and net income Financial Results Revenue Net Income Operating Income Integrated BioPharma
BRIEF published on 09/23/2025 at 21:45, 1 year 1 month ago Integrated BioPharma Reports Fiscal Year 2025 Results Financial Results Revenue Growth Net Income Operating Income Contract Manufacturing
PRESS RELEASE published on 09/23/2025 at 21:40, 1 year 1 month ago Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2025 Integrated BioPharma, Inc. reports 11.8% increase in revenue for Q2 2025. Operating income rises in Q2 & FY 2025. Net loss in Q2 but net income grows for FY 2025 Revenue Increase Net Income Net Loss Operating Income Integrated BioPharma
BRIEF published on 05/14/2025 at 21:35, 1 year 5 months ago Integrated BioPharma, Inc. Posts Financial Results for Q1 2025 Financial Results Revenue Growth Operating Income Q1 2025 Key Customers
PRESS RELEASE published on 05/14/2025 at 21:30, 1 year 5 months ago Integrated BioPharma Reports Results for its Quarter Ended March 31, 2025 Integrated BioPharma, Inc. reports a 6.1% revenue increase for Q1 2025 compared to Q1 2024. Company had operating income and net income growth. Key focus on core business and expanding customer base Financial Results Revenue Increase Net Income Operating Income Integrated BioPharma
Published on 11/02/2026 at 23:15, 5 hours 24 minutes ago ATHA Energy Announces Issuance of Common Shares in Satisfaction of US$25 Million Convertible Debenture Interest Payment Obligations
Published on 11/02/2026 at 22:30, 6 hours 9 minutes ago Sparton Files Morrison Mine N-I 43-101 Technical Report
Published on 11/02/2026 at 17:00, 11 hours 39 minutes ago PPX Mining Initiates Operating Permit Process for Igor Processing Plant
Published on 11/02/2026 at 17:00, 11 hours 39 minutes ago QNX Launches Global Developer Hackathon with $50,000 in Prizes to Accelerate Innovation in Mission-Critical Systems
Published on 11/02/2026 at 16:15, 12 hours 24 minutes ago ACCESS Newswire Launches SPOT, Seven AI Agents That Check Every Press Release Before Submission
Published on 11/03/2026 at 03:30, 1 hour 9 minutes ago ADTRAN Holdings, Inc. reports third quarter 2026 financial results
Published on 11/03/2026 at 03:25, 1 hour 14 minutes ago How President Xi Jinping Has Charted the Course for Boosting China's Strength in Finance: Pursuing a Path of Financial Development with Chinese Characteristics
Published on 11/03/2026 at 02:55, 1 hour 44 minutes ago WESCAN GOLDFIELDS ANNOUNCES ENGAGEMENT OF RED CLOUD SECURITIES FOR LIQUIDITY SERVICES
Published on 11/02/2026 at 23:11, 5 hours 28 minutes ago EQS-Adhoc: HUGO BOSS AG: HUGO BOSS UPDATES ITS FULL YEAR 2026 OUTLOOK
Published on 11/02/2026 at 22:05, 6 hours 34 minutes ago Abivax to Participate in Upcoming Fall Investor Conferences
Published on 11/02/2026 at 18:30, 10 hours 9 minutes ago Disclosure of transactions in own shares from October 26 to October 30, 2026
Published on 11/02/2026 at 18:17, 10 hours 22 minutes ago Reporting on share buyback transactions carried out between October 28 and October 29, 2026
Published on 11/02/2026 at 18:00, 10 hours 39 minutes ago Covivio - Information on total number of voting rights and share capital
Published on 11/02/2026 at 17:59, 10 hours 40 minutes ago Saint-Gobain completes the divestment of its Dahl specialist distribution business in Sweden, Norway and Denmark
